Mersana Therapeutics buy Truist Financial Co.
Start price
16.05.25
/
50%
€0.30
Target price
16.05.26
€8.93
Performance (%)
-13.68%
End price
17.05.26
-
Summary
This prediction is currently being closed. The prediction for Mersana Therapeutics disappoints with a performance of -13.68%. Truist_Financial_Co_ has a follow-up prediction for Mersana Therapeutics where he still thinks Mersana Therapeutics is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mersana Therapeutics | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its price target raised by analysts at Truist Financial Co. from $9.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Mersana Therapeutics
Stopped prediction by Truist_Financial_Co_ for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€5.00
29.02.24
29.02.24
€8.30
28.02.25
28.02.25
-90.28%
01.03.25
01.03.25
